Risk factors and incidence of cytomegalovirus viremia and disease in pediatric patients with allogeneic hematopoietic stem cell transplantation: An 8-year single-center experience in Latin America.
Ana M. AristizabalPaola PerezJaime A PatiñoAlexis A FrancoEliana Manzi TarapuesEstefania BeltranDiego Medina-ValenciaPublished in: Pediatric transplantation (2022)
During the study period, the incidence of cytomegalovirus disease was similar to that of other pediatric reports, but the incidence of viremia was higher. Pre-emptive therapy has diminished disease rates and death due to infection. Viral load cutoff points should be standardized to guide treatment and avoid myelotoxicity.